메뉴 건너뛰기




Volumn 1303, Issue , 2007, Pages 10-20

Global management of high risk patients: Integrated primary cardiovascular prevention in diabetics

Author keywords

Cardiovascular disease; Clinical guidelines; Diabetes mellitus; Evidence based medicine; History of medicine; Prevention; Risk factors

Indexed keywords


EID: 34447626283     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2007.03.028     Document Type: Article
Times cited : (3)

References (52)
  • 2
    • 0003527257 scopus 로고
    • Rothman K.J. (Ed), Epidemiology Resources, Boston
    • In: Rothman K.J. (Ed). Causal Inference (1988), Epidemiology Resources, Boston
    • (1988) Causal Inference
  • 3
    • 34447627418 scopus 로고    scopus 로고
    • Hume D. A treatise of human nature. Oxford: Oxford University Press, 1888; 2nd edition, 1978 (original publication, 1739).
  • 5
    • 0036778489 scopus 로고    scopus 로고
    • Evolution of the epidemiologic context of cardiovascular diseases: a critical historical approach
    • Gensini G.F., Conti A.A., and Lippi D. Evolution of the epidemiologic context of cardiovascular diseases: a critical historical approach. Ital. Heart J 3 Suppl 6 (2002) 5S-8S
    • (2002) Ital. Heart J , vol.3 , Issue.SUPPL. 6
    • Gensini, G.F.1    Conti, A.A.2    Lippi, D.3
  • 6
    • 0033735227 scopus 로고    scopus 로고
    • Is evidence-based medicine really a craze? Surely it is fashionable to criticize it. A methodologic comment from the Centro Italiano per la Medicina Basata sulle Prove (Italian Center for Evidence-Based Medicine)
    • Conti A.A., Galanti C., and Gensini G.F. Is evidence-based medicine really a craze? Surely it is fashionable to criticize it. A methodologic comment from the Centro Italiano per la Medicina Basata sulle Prove (Italian Center for Evidence-Based Medicine). Ital. Heart J Suppl 1 (2000) 1192-1195
    • (2000) Ital. Heart J , vol.SUPPL. 1 , pp. 1192-1195
    • Conti, A.A.1    Galanti, C.2    Gensini, G.F.3
  • 7
    • 31844443695 scopus 로고
    • The environment and disease: association or causation?
    • Hill A.B. The environment and disease: association or causation?. Proc. R. Soc. Med. 58 (1965) 295-300
    • (1965) Proc. R. Soc. Med. , vol.58 , pp. 295-300
    • Hill, A.B.1
  • 8
    • 0022496624 scopus 로고
    • On the logic of causal inference
    • Weed D.L. On the logic of causal inference. Am. J. Epidemiol. 123 (1986) 965-979
    • (1986) Am. J. Epidemiol. , vol.123 , pp. 965-979
    • Weed, D.L.1
  • 9
    • 0003408870 scopus 로고
    • Harris MJ. (Ed), National Institutes of Health, Bethesda, MD
    • In: Harris MJ. (Ed). Diabetes in America. 2nd edition (1995), National Institutes of Health, Bethesda, MD
    • (1995) Diabetes in America. 2nd edition
  • 10
    • 0031851293 scopus 로고    scopus 로고
    • Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation
    • Alberti K., and Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet. Med. 15 (1998) 539-553
    • (1998) Diabet. Med. , vol.15 , pp. 539-553
    • Alberti, K.1    Zimmet, P.2
  • 11
    • 34447643669 scopus 로고    scopus 로고
    • BMJ Clinical Evidence Online, BMJ Publishing Group, London, UK; available online at: http://www.clinicalevidence.com/ceweb/products/online_only.jsp (accessed on April 13th, 2007).
  • 12
    • 0029993074 scopus 로고    scopus 로고
    • Epidemiology of late diabetic complications. A basis for the development and evaluation of preventive programs
    • Krolewski A.S., Warram J.H., and Freire M.B. Epidemiology of late diabetic complications. A basis for the development and evaluation of preventive programs. Endocrinol. Metab. Clin. N. Am. 25 (1996) 217-242
    • (1996) Endocrinol. Metab. Clin. N. Am. , vol.25 , pp. 217-242
    • Krolewski, A.S.1    Warram, J.H.2    Freire, M.B.3
  • 13
    • 33745699562 scopus 로고    scopus 로고
    • Metabolic syndrome, new onset diabetes and new end points in cardiovascular trials
    • Haffner S.M., et al. Metabolic syndrome, new onset diabetes and new end points in cardiovascular trials. J. Cardiovasc. Pharmacol. 47 (2006) 469-475
    • (2006) J. Cardiovasc. Pharmacol. , vol.47 , pp. 469-475
    • Haffner, S.M.1
  • 14
    • 0003571561 scopus 로고    scopus 로고
    • Braunwald E., Fauci A.S., Kasper D.L., Hauser S.L., Longo D.L., and Jameson J.L. (Eds), McGraw-Hill, New York
    • In: Braunwald E., Fauci A.S., Kasper D.L., Hauser S.L., Longo D.L., and Jameson J.L. (Eds). Harrison's Principles of Internal Medicine. 15th edition (2001), McGraw-Hill, New York
    • (2001) Harrison's Principles of Internal Medicine. 15th edition
  • 15
    • 0030746637 scopus 로고    scopus 로고
    • The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature
    • Dinneen S.F., and Gerstein H.C. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch. Intern. Med. 157 (1997) 1413-1438
    • (1997) Arch. Intern. Med. , vol.157 , pp. 1413-1438
    • Dinneen, S.F.1    Gerstein, H.C.2
  • 16
    • 0004225302 scopus 로고    scopus 로고
    • Goldman L., and Ausiello D. (Eds), Saunders, Philadelphia
    • In: Goldman L., and Ausiello D. (Eds). Cecil Textbook of Medicine. 22nd edition (2004), Saunders, Philadelphia
    • (2004) Cecil Textbook of Medicine. 22nd edition
  • 17
    • 1442303535 scopus 로고    scopus 로고
    • Weatherall D.J., Cox T.M., Firth J.D., and Benz E.J. (Eds), Oxford Medical Publications, Oxford
    • In: Weatherall D.J., Cox T.M., Firth J.D., and Benz E.J. (Eds). Oxford Textbook of Medicine. 4th edition (2003), Oxford Medical Publications, Oxford
    • (2003) Oxford Textbook of Medicine. 4th edition
  • 18
    • 34447617258 scopus 로고    scopus 로고
    • Update in the management of obesity
    • Suastika K. Update in the management of obesity. Acta Med. Indones. 38 (2006) 231-237
    • (2006) Acta Med. Indones. , vol.38 , pp. 231-237
    • Suastika, K.1
  • 19
    • 4644238349 scopus 로고    scopus 로고
    • Clinicians' manual on total risk management
    • Davenport L. (Ed), Science Press, London
    • Wood D., et al. Clinicians' manual on total risk management. In: Davenport L. (Ed). A Guide to Prevention of Coronary Heart Disease (2000), Science Press, London
    • (2000) A Guide to Prevention of Coronary Heart Disease
    • Wood, D.1
  • 20
    • 33846083971 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular diseases in people with diabetes mellitus. A scientific statement from the American Heart Association and the American Diabetes Association
    • Buse J.B., et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus. A scientific statement from the American Heart Association and the American Diabetes Association. Circulation 115 (2007) 114-126
    • (2007) Circulation , vol.115 , pp. 114-126
    • Buse, J.B.1
  • 21
    • 0033009672 scopus 로고    scopus 로고
    • Relationship between blood glucose level and mortality in type 2 diabetes mellitus: a systematic review
    • Groeneveld Y., et al. Relationship between blood glucose level and mortality in type 2 diabetes mellitus: a systematic review. Diabet. Med. 16 (1999) 2-13
    • (1999) Diabet. Med. , vol.16 , pp. 2-13
    • Groeneveld, Y.1
  • 22
    • 0027370108 scopus 로고
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
    • DCCT Research Group
    • DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977-986
    • (1993) N. Engl. J. Med. , vol.329 , pp. 977-986
  • 23
    • 0028940198 scopus 로고
    • Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial
    • DCCT Research Group
    • DCCT Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am. J. Cardiol. 75 (1995) 894-903
    • (1995) Am. J. Cardiol. , vol.75 , pp. 894-903
  • 24
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. UKPDS 33
    • UK Prospective Diabetes Study Group
    • UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. UKPDS 33. Lancet 352 (1998) 837-853
    • (1998) Lancet , vol.352 , pp. 837-853
  • 25
    • 0032511566 scopus 로고    scopus 로고
    • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. UKPDS 34
    • UK Prospective Diabetes Study Group
    • UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. UKPDS 34. Lancet 352 (1998) 854-865
    • (1998) Lancet , vol.352 , pp. 854-865
  • 26
    • 32144442853 scopus 로고    scopus 로고
    • Cardiometabolic risk assessment: an approach to the prevention of cardiovascular disease and diabetes mellitus
    • Vasudevan A.R., and Ballantyne C.M. Cardiometabolic risk assessment: an approach to the prevention of cardiovascular disease and diabetes mellitus. Clin. Cornerstone 7 (2005) 7-16
    • (2005) Clin. Cornerstone , vol.7 , pp. 7-16
    • Vasudevan, A.R.1    Ballantyne, C.M.2
  • 27
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • Hansson L., et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351 (1998) 1751-1762
    • (1998) Lancet , vol.351 , pp. 1751-1762
    • Hansson, L.1
  • 28
    • 84921431153 scopus 로고    scopus 로고
    • Antihypertensive therapy for preventing cardiovascular complications in people with diabetes
    • Fuller J., et al. Antihypertensive therapy for preventing cardiovascular complications in people with diabetes. Cochrane Database Syst. Rev. 1 (2003) CD002188
    • (2003) Cochrane Database Syst. Rev. , vol.1
    • Fuller, J.1
  • 29
    • 4644346499 scopus 로고    scopus 로고
    • The practical implementation taskforce for the prevention of cardiovascular disease. Prevention of cardiovascular disease: an evidence-based clinical aid 2004. MJA Focus vol. 181 (2004) F1-F14
    • (2004) MJA Focus , vol.181
  • 30
    • 0034700790 scopus 로고    scopus 로고
    • Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and the MICRO-HOPE substudy
    • Heart Outcomes Prevention Evaluation (HOPE) Study Investigators
    • Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and the MICRO-HOPE substudy. Lancet 355 (2000) 253-259
    • (2000) Lancet , vol.355 , pp. 253-259
  • 31
    • 0032511580 scopus 로고    scopus 로고
    • Tight blood pressure control and risk of macrovascular complications in type 2 diabetes. UKPDS 38
    • UK Prospective Diabetes Study Group
    • UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular complications in type 2 diabetes. UKPDS 38. BMJ 317 (1998) 703-713
    • (1998) BMJ , vol.317 , pp. 703-713
  • 32
    • 0032511601 scopus 로고    scopus 로고
    • Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 39
    • UK Prospective Diabetes Study Group
    • UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 39. BMJ 317 (1998) 713-720
    • (1998) BMJ , vol.317 , pp. 713-720
  • 33
    • 0035922447 scopus 로고    scopus 로고
    • Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
    • Lewis E., et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 345 (2001) 851-860
    • (2001) N. Engl. J. Med. , vol.345 , pp. 851-860
    • Lewis, E.1
  • 34
    • 0035922444 scopus 로고    scopus 로고
    • The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
    • Parving H., et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N. Engl. J. Med. 345 (2001) 870-878
    • (2001) N. Engl. J. Med. , vol.345 , pp. 870-878
    • Parving, H.1
  • 35
    • 0035922441 scopus 로고    scopus 로고
    • Effect of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    • Brenner B., et al. Effect of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345 (2001) 861-869
    • (2001) N. Engl. J. Med. , vol.345 , pp. 861-869
    • Brenner, B.1
  • 36
    • 0037160969 scopus 로고    scopus 로고
    • Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
    • Lindholm L., et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359 (2002) 1004-1010
    • (2002) Lancet , vol.359 , pp. 1004-1010
    • Lindholm, L.1
  • 37
    • 0034685403 scopus 로고    scopus 로고
    • Major cardiovascular events in hypertensive patients randomised to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    • ALLHAT Collaborative Research Group
    • ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomised to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 283 (2000) 1967-1975
    • (2000) JAMA , vol.283 , pp. 1967-1975
  • 38
    • 0033522149 scopus 로고    scopus 로고
    • Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
    • Tuomilehto J., et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N. Engl. J. Med. 340 (1999) 677-684
    • (1999) N. Engl. J. Med. , vol.340 , pp. 677-684
    • Tuomilehto, J.1
  • 39
    • 0031944128 scopus 로고    scopus 로고
    • Outcome results of the fosinopril versus amlodipine cardiovascular events randomised trial (FACET) in patients with hypertension and NIDDM
    • Tatti P., et al. Outcome results of the fosinopril versus amlodipine cardiovascular events randomised trial (FACET) in patients with hypertension and NIDDM. Diabetes Care 21 (1998) 597-603
    • (1998) Diabetes Care , vol.21 , pp. 597-603
    • Tatti, P.1
  • 40
    • 0032485350 scopus 로고    scopus 로고
    • The effect of nisoldipine as compared with enalapril on cardiovascular events in patients with NIDDM and hypertension
    • Estacio R.O., et al. The effect of nisoldipine as compared with enalapril on cardiovascular events in patients with NIDDM and hypertension. N. Engl. J. Med. 338 (1998) 645-652
    • (1998) N. Engl. J. Med. , vol.338 , pp. 645-652
    • Estacio, R.O.1
  • 41
    • 0033034404 scopus 로고    scopus 로고
    • Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension. The Captopril Prevention Project (CAPPP) randomised trial
    • Hansson L., et al. Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension. The Captopril Prevention Project (CAPPP) randomised trial. Lancet 353 (1999) 611-616
    • (1999) Lancet , vol.353 , pp. 611-616
    • Hansson, L.1
  • 42
    • 6344246164 scopus 로고    scopus 로고
    • Prevention of cardiovascular complications of diabetes mellitus by aspirin
    • Nobles-James C., James E.A., and Sowers J.R. Prevention of cardiovascular complications of diabetes mellitus by aspirin. Cardiovasc. Drug Rev. 22 (2004) 215-226
    • (2004) Cardiovasc. Drug Rev. , vol.22 , pp. 215-226
    • Nobles-James, C.1    James, E.A.2    Sowers, J.R.3
  • 43
    • 0026775578 scopus 로고
    • Aspirin effects on mortality and morbidity in patients with diabetes mellitus
    • ETDRS Investigators
    • ETDRS Investigators. Aspirin effects on mortality and morbidity in patients with diabetes mellitus. JAMA 268 (1992) 1292-1300
    • (1992) JAMA , vol.268 , pp. 1292-1300
  • 44
    • 0024406369 scopus 로고
    • Final report on the aspirin component of the ongoing Physicians' Health Study
    • Steering Committee of the Physicians' Health Study Research Group
    • Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N. Engl. J. Med. 321 (1989) 129-135
    • (1989) N. Engl. J. Med. , vol.321 , pp. 129-135
  • 45
    • 0028120906 scopus 로고
    • Collaborative overview of randomised trials of antiplatelet therapy I: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration (ATC)
    • Collaborative overview of randomised trials of antiplatelet therapy I: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration (ATC). BMJ 308 (1994) 81-106
    • (1994) BMJ , vol.308 , pp. 81-106
  • 46
    • 33750590325 scopus 로고    scopus 로고
    • Rising to the challenge of treating high-risk patients
    • Guthrie R.M. Rising to the challenge of treating high-risk patients. Am. J. Manag. Care 12 (2006) S318-S324
    • (2006) Am. J. Manag. Care , vol.12
    • Guthrie, R.M.1
  • 47
    • 0032572086 scopus 로고    scopus 로고
    • Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
    • Downs J.R., et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279 (1998) 1615-1622
    • (1998) JAMA , vol.279 , pp. 1615-1622
    • Downs, J.R.1
  • 48
    • 0037840242 scopus 로고    scopus 로고
    • MRC/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
    • Heart Protection Study Collaborative Group
    • Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361 (2003) 2005-2016
    • (2003) Lancet , vol.361 , pp. 2005-2016
  • 49
    • 0031922041 scopus 로고    scopus 로고
    • Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study
    • Elkeles R.S., et al. Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study. Diabetes Care 21 (1998) 641-648
    • (1998) Diabetes Care , vol.21 , pp. 641-648
    • Elkeles, R.S.1
  • 50
    • 0026710526 scopus 로고
    • Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study
    • Koskinen P., et al. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care 15 (1992) 820-825
    • (1992) Diabetes Care , vol.15 , pp. 820-825
    • Koskinen, P.1
  • 51
    • 0038171517 scopus 로고    scopus 로고
    • Evidence-based evaluation of benefits in therapeutic interventions: methodologically controlled and non-randomly assigned reflections on the number needed to treat
    • Gensini G.F., and Conti A.A. Evidence-based evaluation of benefits in therapeutic interventions: methodologically controlled and non-randomly assigned reflections on the number needed to treat. Ital. Heart J 4 (2003) 80-83
    • (2003) Ital. Heart J , vol.4 , pp. 80-83
    • Gensini, G.F.1    Conti, A.A.2
  • 52
    • 0037387809 scopus 로고    scopus 로고
    • Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy
    • Berl T., et al. Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Ann. Intern. Med. 138 (2003) 542-549
    • (2003) Ann. Intern. Med. , vol.138 , pp. 542-549
    • Berl, T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.